Jobs / United States / Genscript USA INC
Strategic Product Manager, Biotech Reagents Portfolio
Genscript USA INC · 🇺🇸 Piscataway, New Jersey, United States
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 31 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 3 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Genscript USA INC paid sponsored hires in similar roles2 certified filings for “Regional Marketing Manager, US” (Market Research Analysts and Marketing Specialists) in NJ: $90k–$90k, median $90k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Genscript USA INC
The US Department of Labor certified 31 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 3 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Genscript USA INC →
About the role
About GenScript Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a well-recognized biotechnology company, GenScript has a team of approximately 6,165 employees and has served more than 200,000 customers across over 100 countries and regions. Product Planning and Development, Scientific Product Strategy – Life Science & Biotech Reagents Position Type: Full-time, Strategic/Front-end Portfolio Management The ideal candidate will have a strong scientific background and industry experience in biotechnology or life sciences, combined with experience in product management, product strategy, or related roles . We are particularly interested in candidates who can leverage their scientific expertise and industry knowledge to drive product strategy and translate scientific insights into business and product opportunities. This is a front-end product strategy and planning role where you'll define what GenScript should build over the next 3–5 years by identifying unmet customer needs, evaluating emerging technologies, and shaping the future portfolio of life science research reagents. Location: Remote , with occasional travel to Piscataway, New Jersey Compensation: The estimated salary range is $125,000 - $155,000 based upon experience level. Job Scope: At GenScript, we believe great products begin long before the first experiment. Under GenScript's Catalog Products Business Unit, you won't simply manage existing products—you will design the future of our life science research portfolio. This role sits at the intersection of science, technology, customer insight, and business strategy, helping define WHAT products GenScript should build over the next 3–5 years. Focused purely on front-end strategic planning, you will define the target specifications (What) while liberating R&D to explore the best execution (How). You will work closely with R&D, Marketing, Business Development, Commercial, and executive leadership to discover unmet customer needs, identify emerging technology opportunities, design high-barrier product portfolios, and shape long-term innovation strategy. Key Responsibilities (What You'll Do): 1) Design Future Product Portfolio & Roadmaps • Portfolio Strategy: Build long-term product portfolio strategies across antibodies, recombinant proteins, enzymes, bioassays, protein purification products, Cell & Gene Therapy (GCT) reagents, and emerging technology platforms. • White Space Identification: Pinpoint technology white spaces and unarticulated customer needs to establish a sustainable, high-margin product menu. • Strategic Roadmapping: Formulate and maintain future product roadmaps aligned with global business unit growth objectives. 2) Customer Insights & Actionable VOC • Deep Workflow Understanding: Transform scientific insights into commercial opportunities by deep-diving into customer workflows, Jobs-to-be-Done (JTBD), and Voice of the Customer (VOC). • Market Intuition: Keep a pulse on emerging research trends, technology evolution, and the global competitive landscape. Your goal is to discover latent opportunities that customers have not yet articulated. 3) Shape Innovation & Platform Strategy • Multidimensional Evaluation: Evaluate future portfolio opportunities by integrating scientific feasibility, customer value, market potential, competitive differentiation, intellectual property (IP), and business economics. • Make vs. Buy Assessment: Conduct thorough "Build vs. Buy vs. Partner" assessments to support annual strategic pla